Influence of Genetic Variations on Levels of Inflammatory Markers of Healthy Subjects at Baseline and One Week after Clopidogrel Therapy; Results of a Preliminary Study

af Shahabi, Payman, Siest, Gérard, Herbeth, Bernard, Lambert, Daniel, Masson, Christine, Hulot, Jean-Sébastien, Bertil, Sébastien, Gaussem, Pascale, Visvikis-Siest, Sophie
Udgivet 2013

Impact of regular physical activity on weekly warfarin dose requirement

af Rouleau-Mailloux, Étienne, Shahabi, Payman, Dumas, Stéphanie, Feroz Zada, Yassamin, Provost, Sylvie, Hu, Jason, Nguyen, Jacqueline, Bouchama, Nawal, Mongrain, Ian, Talajic, Mario, Tardif, Jean-Claude, Perreault, Sylvie, Dubé, Marie-Pierre
Udgivet i J Thromb Thrombolysis (2015)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort

af Shahabi, Payman, Lamothe, Félix, Dumas, Stéphanie, Rouleau-Mailloux, Étienne, Feroz Zada, Yassamin, Provost, Sylvie, Asselin, Geraldine, Mongrain, Ian, Valois, Diane, Gaulin Marion, Marie-Josée, Lemieux Perreault, Louis-Philippe, Perreault, Sylvie, Dubé, Marie-Pierre
Udgivet i Pharmacogenomics J (2018)

An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance

af Shahabi, Payman, Scheinfeldt, Laura B., Lynch, Daniel E., Schmidlen, Tara J., Perreault, Sylvie, Keller, Margaret A., Kasper, Rachel, Wawak, Lisa, Jarvis, Joseph P., Gerry, Norman P., Gordon, Erynn S., Christman, Michael F., Dubé, Marie-Pierre, Gharani, Neda
Udgivet i Thromb Haemost (2016)

Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study

af Perreault, Sylvie, Shahabi, Payman, Côté, Robert, Dumas, Stéphanie, Rouleau‐Mailloux, Étienne, Feroz Zada, Yassamin, Provost, Sylvie, Mongrain, Ian, Dorais, Marc, Huynh, Thao, Kouz, Simon, Diaz, Ariel, Blostein, Mark, de Denus, Simon, Turgeon, Jacques, Ginsberg, Jeffrey, Lelorier, Jacques, Lalonde, Lyne, Busque, Lambert, Kassis, Jeannine, Talajic, Mario, Tardif, Jean‐Claude, Dubé, Marie‐Pierre
Udgivet i Clin Cardiol (2018)